THE PHARMACOPHORE OF THE HUMAN C5A ANAPHYLATOXIN

被引:42
|
作者
TOTH, MJ
HUWYLER, L
BOYAR, WC
BRAUNWALDER, AF
YARWOOD, D
HADALA, J
HASTON, WO
SILLS, MA
SELIGMANN, B
GALAKATOS, N
机构
[1] Department of Biological Technologies, Ciba-Geigy Corporation, Summit, New Jersey
关键词
C5A; PHARMACOPHORE; PROTEIN HYBRIDS; SITE-DIRECTED MUTAGENESIS; STRUCTURE/FUNCTION;
D O I
10.1002/pro.5560030802
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have determined which amino acids contribute to the pharmacophore of human C5a, a potent inflammatory mediator. A systematic mutational analysis of this 74-amino acid protein was performed and the effects on the potency of receptor binding and of C5a-induced intracellular calcium ion mobilization were measured. This analysis included the construction of hybrids between C5a and the homologous but unreactive C3a protein and site-directed mutagenesis. Ten noncontiguous amino acids from the structurally well-defined 4-helix core domain (amino acids 1-63) and the C-terminal arginine-containing tripeptide were found to contribute to the pharmacophore of human C5a. The 10 mostly charged amino acids from the core domain generally made small incremental contributions toward binding affinity, some of which were independent. Substitutions of the C-terminal amino acid Arg 74 produced the largest single effect. We also found the connection between these 2 important regions to be unconstrained.
引用
收藏
页码:1159 / 1168
页数:10
相关论文
共 50 条
  • [31] Pharmacophore modeling, atom based 3D-QSAR and Molecular docking approaches to screen C-X-C chemokine receptor type 4 antagonists as microbicides for human immunodeficiency virus-1
    Ramachandran R.
    Piramanyagam S.
    VirusDisease, 2017, 28 (3) : 272 - 280
  • [32] Design, Synthesis of Some Innovative Indolo[3,2-c]Isoquinoline-5-One Analogs and Associated Bioactivities, Pharmacophore, Molecular Docking, MEP, and Conceptual DFT Studies
    Verma, Vaijinath A.
    Shinde, Venkat M.
    Saundane, Anand R.
    Meti, Rajkumar S.
    Vennapu, Dushyanth R.
    POLYCYCLIC AROMATIC COMPOUNDS, 2023, 43 (09) : 8408 - 8425
  • [33] Pharmacophore Modeling, Atom based 3D-QSAR and Docking Studies on ADAMTS-5 Inhibitors
    Suganya, Rathi P.
    Kalva, Sukesh
    Saleena, Lilly M.
    BIOSCIENCE, BIOCHEMISTRY AND BIOINFORMATICS, 2011, 5 : 378 - 382
  • [34] Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
    Shah, Abhishek
    Lobo, Richard
    Krishnadas, Nandakumar
    Pai, Aravinda
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2018, 52 (04) : S296 - S302
  • [35] IDENTIFICATION OF 5-HYDROXYTRYPTAMINE-1A RECEPTOR AGENTS USING A COMPOSITE PHARMACOPHORE ANALYSIS AND CHEMICAL DATABASE SCREENING
    SLEIGHT, AJ
    PEROUTKA, SJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1991, 343 (02) : 109 - 116
  • [36] ON THE PROTEIN-KINASE-C PHARMACOPHORE - SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 4-HYDROXYLATED ANALOGS OF INGENOL
    WINKLER, JD
    HONG, BC
    KIM, S
    LEWIN, NE
    BLUMBERG, PM
    SYNLETT, 1995, (05) : 533 - 535
  • [37] Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer’s disease
    Degani, Mariam S. (ms.degani@ictmumbai.edu.in), 1600, Bentham Science Publishers (10): : 335 - 348
  • [38] Pharmacophore Based 3DQSAR of Phenothiazines as Specific Human Butyrylcholinesterase Inhibitors for Treatment of Alzheimer's Disease
    Kundaikar, Harish S.
    Agre, Neha P.
    Degani, Mariam S.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2014, 10 (04) : 335 - 348
  • [39] Identification of Malaria-Selective Proteasome β5 Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation
    Yasir, Muhammad
    Park, Jinyoung
    Han, Eun-Taek
    Han, Jin-Hee
    Park, Won Sun
    Chun, Wanjoo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [40] Identification of new non-steroidal TGR5 agonists using virtual screening with combined pharmacophore models
    Zhou, Chen
    Zou, Fangxia
    Xu, Yungen
    Zhang, Luyong
    Zha, Xiaoming
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (06) : 2561 - 2572